Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$149K Buy
+20,267
New +$121K ﹤0.01% 2297
2017
Q1
Sell
-3,073
Closed -$42K 3792
2016
Q4
$42K Buy
3,073
+1,684
+121% +$25.7K ﹤0.01% 3128
2016
Q3
$29K Buy
+1,389
New +$22K ﹤0.01% 2881
2016
Q2
Sell
-1,195
Closed -$20K 3379
2016
Q1
$20K Sell
1,195
-250
-17% -$4.46K ﹤0.01% 2598
2015
Q4
$31K Buy
1,445
+315
+28% +$6.91K ﹤0.01% 3243
2015
Q3
$25K Sell
1,130
-750
-40% -$18.2K ﹤0.01% 3125
2015
Q2
$43K Sell
1,880
-27
-1% -$663 ﹤0.01% 3092
2015
Q1
$48K Buy
1,907
+533
+39% +$14.7K ﹤0.01% 2834
2014
Q4
$34K Buy
+1,374
New +$35.2K ﹤0.01% 3516
2014
Q3
Sell
-1,761
Closed -$55K 4105
2014
Q2
$55K Buy
+1,761
New +$73.6K ﹤0.01% 3419

Other funds holding VXRT

Virtu KCG Holdings's VXRT Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Vaxart (VXRT) in Q2 2017: 20,267 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #2297 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in VXRT as recently as Q4 2016.

Virtu KCG Holdings first reported a position in VXRT in Q2 2014 and has held it in 10 quarters since. 32 funds tracked by Wall St. Rank hold VXRT as of Q2 2017.

  • Virtu KCG Holdings held 20,267 shares of Vaxart worth $149K as of Q2 2017.
  • Vaxart was a new Virtu KCG Holdings position in Q2 2017.
  • Vaxart made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2297 holding.
  • Virtu KCG Holdings first reported a position in Vaxart in Q2 2014 and has held it in 10 quarters since.
  • 32 funds tracked by Wall St. Rank held Vaxart as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.